Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-17 BELVIN MARCIA SVP, Chief Scientific Officer Sale −31,492 $6.42 $202K 300,760
2026-02-02 BELVIN MARCIA SVP, Chief Scientific Officer Grant or award +60,000 332,252
2026-02-02 BELVIN MARCIA SVP, Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +250,000 250,000
2025-09-26 BELVIN MARCIA SVP, Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +36,300 36,300
2025-09-26 BELVIN MARCIA SVP, Chief Scientific Officer Grant or award · Performance Stock Units (PSUs) +18,150 18,150
2025-06-16 BELVIN MARCIA SVP, Chief Scientific Officer Sale −13,884 $2.69 $37K 272,252
2025-06-13 BELVIN MARCIA SVP, Chief Scientific Officer Exercise or conversion +37,500 286,136
2025-06-13 BELVIN MARCIA SVP, Chief Scientific Officer Exercise or conversion · Performance Stock Units −37,500 0
2025-03-18 BELVIN MARCIA SVP, Chief Scientific Officer Sale −19,512 $0.60 $12K 248,636
2025-02-04 BELVIN MARCIA SVP, Chief Scientific Officer Grant or award +35,000 210,648
2025-02-04 BELVIN MARCIA SVP, Chief Scientific Officer Grant or award +57,500 268,148
2025-02-04 BELVIN MARCIA SVP, Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000
2025-02-04 BELVIN MARCIA SVP, Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +115,000 115,000
2025-02-04 BELVIN MARCIA SVP, Chief Scientific Officer Grant or award +30,000 205,648
2025-02-04 BELVIN MARCIA SVP, Chief Scientific Officer Grant or award +57,500 263,148
2025-02-04 BELVIN MARCIA SVP, Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +140,000 140,000
2025-02-04 BELVIN MARCIA SVP, Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +115,000 115,000
2024-08-20 BELVIN MARCIA SVP, Chief Scientific Officer Exercise or conversion +11,250 179,829
2024-08-20 BELVIN MARCIA SVP, Chief Scientific Officer Sale −4,181 $1.23 $5K 175,648
2024-08-20 BELVIN MARCIA SVP, Chief Scientific Officer Exercise or conversion · Performance Stock Units (PSUs) −11,250 0

Page 1 of 2 · 30 trades